Dallas, Texas (PRWEB) June 19, 2014
Acute migraine treatment market is dominant by Triptans and most of them are available as pills. Triptans like Sumatriptan and Zolmitriptan are also available as nasal sprays whereas rizatriptan and zolmitriptan are available as tablets that dissolve in mouth. In next 5-10 years, cost of migraine drugs is anticipated to decline due to many generic entrants as most of them are losing their patents. Growing awareness of migraine in the emerging countries and fall in prices will facilitate the growth of anti-migraine drugs market. In addition, with the development of new treatment therapies like calcitonin gene-related peptides (CGRP) receptor antagonist and BOTOX the demand for anti-migraine drugs is anticipated to grow further.
Complete report available @ http://www.marketreportsonline.com/342258.html.
The report titled "Global Anti-Migraine Drugs Market: Trends and Opportunities (2014-2019)" provides an insight into migraine drugs with a special focus on Triptans. The report also includes the market value, segmentation, types of diagnosis and treatment for migraine. It also discusses key growth drivers and upcoming trends of the market. Further, key manufacturers of anti-migraine drugs like Endo International Inc, Imapc Laboratories, GlaxoSmithKline and Pfizer Inc. are profiled in the report.
Segments Coverage: Triptans and Ergot Alkaloids
Company Coverage: Endo International Inc., IMPAX Laboratories Inc., GlaxoSmith Kline (GSK) and Pfizer Inc.
Purchase a copy of this report @ http://www.marketreportsonline.com/contacts/purchase.php?name=342258.
Migraine, a condition of recurring headaches and is accompanied by symptoms like nausea, vomiting, dizziness and sensitivity to light and noise ranks among the World's Top 20 disabling medical illnesses. It is anticipated that launches of many generic migraine drugs over the next several years will steadily increase diagnosis and drug-treatment rates, leading to sustained annual global growth of anti-migraine drugs market. Other factors contributing to the growth of these drugs include awareness among the people about proper diagnosis and treatment of migraine, rise in medical expenditures and new drugs launches.
The US is the largest market for anti-migraine drugs and there are number of companies that manufacture these drugs. Major companies include Impax, Endo Pharmaceuticals, Pfizer, GlaxoSmith Kline, Nautilus and Allergan.
Major points from Table of Contents (http://www.marketreportsonline.com/342258-toc.html) are listed below:
Table of Contents
1. Executive Summary
3. Anti-Migraine Drugs Market
4. The US Migraine Market
5. Migraine Market: Drivers & Challenges
6. Migraine Market: Key Challenges
7. Migraine Market: Upcoming Trends
8. Migraine Market: Competitive Landscape
9. Migraine Market: Company Profiles
List of Tables
Related Report on Pharmaceuticals Market:
Global Aortic Aneurysm Market: Trends and Opportunities (2014-2019): Aortic aneurysm is a general term used for enlargement for aorta which can lead to serious complications as it weakens the walls of the aorta. An aneurysm can develop anywhere along aorta but it mostly occurs in the section running through abdomen (abdominal aneurysms) and chest (thoracic aneurysms). Traditionally, open surgical repair of aneurysm was the only viable treatment option. In due course of time, more advanced minimally invasive Endovascular aneurysm repair (or endovascular aortic repair) (EVAR) or thoracic EVAR (TEVAR) has evolved.
MarketReportsOnline.com is an online database of regional industry research reports, company profiles and SWOT analysis studies for multiple industries, organizations and market segments. Our sales and research experts offer 24 X 7 support to our customers through phone and email communication. Not limited to the , pharmaceuticals industry, MarketReportsOnline.com offers research studies on agriculture, travel & hospitality, chemicals, semiconductor and electronics, retail, environment, food and beverages, automotive, agriculture, consumer goods, healthcare, chemicals, advanced materials, energy and power, medical devices and much more.